Stay updated with breaking news from Nasdaq Afmd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a research note released on Tuesday. The firm issued a sell rating on the biopharmaceutical company’s stock. AFMD has been the subject of a number of other reports. Cantor Fitzgerald restated an overweight rating and set a $7.00 price objective on shares of […]
StockNews.com assumed coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a report released on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently issued reports on AFMD. HC Wainwright restated a buy rating and set a $5.00 price objective on shares of […]
StockNews.com assumed coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a research note released on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Several other equities analysts also recently weighed in on AFMD. Cantor Fitzgerald reaffirmed an overweight rating and issued a $7.00 target price on shares of […]
Research analysts at StockNews.com assumed coverage on shares of Affimed (NASDAQ:AFMD – Get Free Report) in a note issued to investors on Sunday. The firm set a “sell” rating on the biopharmaceutical company’s stock. A number of other research firms also recently weighed in on AFMD. HC Wainwright restated a “buy” rating and issued a […]
Shares of Affimed (NASDAQ:AFMD – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six ratings firms that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year target […]